Bitget App
Mag-trade nang mas matalino
Buy cryptoMarketsTradeFuturesEarnSquareMore
Price
Data
About
PFE stock price forecast
News
Competitors
Tokenization
Crypto
FAQ
Pfizer, Inc. stock logo

Pfizer, Inc.

PFE·NYSE

Huling na-update noong 2026-02-11 11:45 EST. Ang impormasyon sa presyo ng stock ay nagmumula sa TradingView at sumasalamin sa real-time market prices.

Insights
Calculator
News

PFE stock price change

Sa huling araw ng trading, PFE sarado ang stock sa 27.48 USD, na may pagbabago sa presyo ng 1.59% para sa araw.
Trade stock futures

Tungkol kay Bitget

Ang unang Universal Exchange (UEX) sa mundo, na nagbibigay-daan sa mga gumagamit na mag-trade hindi lamang ng mga cryptocurrency, kundi pati na rin ng mga stock, ETF, forex, gold, at mga real-world asset (RWA).
Learn more

PFE key data

Previous close27.48 USD
Market cap156.24B USD
Volume8.48M
P/E ratio20.28
Dividend yield (TTM)6.36%
Dividend amount0.43 USD
Last ex-dividend dateJan 23, 2026
Last payment dateMar 06, 2026
EPS diluted (TTM)1.36 USD
Net income (FY)7.77B USD
Revenue (FY)62.58B USD
Next report dateMay 5, 2026
EPS estimate0.720 USD
Revenue estimate-
Shares float5.68B
Beta (1Y)0.65
Tokenized stocks

Nakarinig ka na ba ng tungkol sa mga tokenized stock?

Isang bagong paraan ng trade stocks — anumang oras, kahit saan, 24/7.

Learn more

Pfizer, Inc. overview

Ang Pfizer Inc ay isang pandaigdigang biopharmaceutical na kumpanya na nakabase sa pananaliksik. Nakikibahagi ito sa pagtuklas, pag-develop, paggawa, marketing, pagbebenta, at distribusyon ng mga produktong biopharmaceutical sa buong mundo. Ang kumpanya ay aktibo sa mga developed at emerging markets upang isulong ang kalusugan, pag-iwas, paggamot, at lunas sa mga pinakakinatatakutang sakit. Itinatag ang kumpanya nina Charles Pfizer Sr. at Charles Erhart noong 1849 at ang punong-tanggapan nito ay nasa New York, NY.
Sector
Teknolohiyang pangkalusugan
Industry
Pharmaceuticals: Pangunahing
CEO
Albert Bourla
Headquarters
New York
Website
pfizer.com
Founded
1849
Employees (FY)
-
Change (1Y)
-
Revenue / Employee (1Y)
-
Net income / Employee (1Y)
-

PFE Pulse

Daily updates on PFE stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• PFE Stock Price 24h change: -0.07%. Mula $27.05 USD hanggang $27.03 USD. Ang bahagyang pagbaba ay nagpapakita ng “wait-and-see” na pananaw matapos ang mga kamakailang pagtaas, habang sinusuri ng mga investor ang magkahalong financial results para sa 2025 at konserbatibong guidance para sa 2026 sa kabila ng positibong datos tungkol sa obesity drug.
• Sa teknikal na pananaw, nagpapakita ang PFE ng “short-term bullish ngunit long-term neutral” na outlook. Ang stock ay nagte-trade sa ibabaw ng 50-day ($25.61) at 200-day ($25.10) moving averages, may neutral na RSI na 54.3 at positibong MACD (0.13), na nagpapahiwatig ng konstruktibong momentum kahit malapit sa 52-week high resistance level na $27.69.
• Nag-ulat ang Pfizer ng positibong Phase 2b data para sa injectable GLP-1 candidate (PF-08653944), na nagpapakita ng matibay na pagbaba ng timbang at inilalagay ang kumpanya upang magpatuloy ng mahigit 20 obesity-related studies sa 2026 para makipagkompetensya kina Eli Lilly at Novo Nordisk.
• Iginawad ng FDA ang Priority Review para sa supplemental Biologics License Application (sBLA) ng Pfizer para sa HYMPAVZI (marstacimab) upang palawakin ang paggamit nito sa paggamot ng Hemophilia A o B, na posibleng magpalawak ng revenue streams ng kumpanya sa specialty medicine.
• Inilunsad ng Pfizer ang cost-savings program sa “TrumpRx” drug pricing platform, nag-aalok ng discounted access sa mahigit 30 gamot para sa milyong Amerikano bilang bahagi ng strategic shift patungo sa mas abot-kayang presyo ng gamot sa US.
• Ang healthcare sector ay dumaranas ng “Darwinian transition” sa Pebrero 2026, kung saan ang mga investor ay lumilipat mula sa mga speculative healthtech firms patungo sa mga established large-cap pharmaceutical companies na may matatag na cash flow at recurring revenue.
• Ang mga hospital operator tulad ng Tenet Healthcare at HCA Healthcare ay nag-uulat ng malakas na admissions at paglago ng serbisyo para sa Q4 2025, bagaman ang tumataas na operating expenses at bahagyang pagbaba sa hospital patient days ay nananatiling pangunahing pokus ng mga investor.
See more
about 1D ago
• Pagbabago ng presyo ng PFE stock sa loob ng 24h: +2.76%. Mula $26.49 USD hanggang $27.22 USD.
• Mula sa teknikal na pananaw, nagpapakita ang PFE ng "short-term recovery trend": ang presyo ay bumalik sa itaas ng 50-day moving average ($25.48) at sinusubukan ang 52-week high ($27.69). Ang RSI na nasa 56.37 ay nagpapahiwatig ng balanseng momentum, hindi overbought o oversold, na sumusuporta sa posibleng breakout kung magpapatuloy ang volume.
• Nag-ulat ang Pfizer ng positibong Phase IIb data para sa kanilang next-gen obesity drug na PF-08653944, na nagpakita ng 12.3% placebo-adjusted weight loss, na nagpapalakas ng kanilang kompetitibong posisyon sa GLP-1 market.
• Tinalo ng Q4 2025 earnings ang mga inaasahan sa kabila ng 3% operational revenue decline na dulot ng pagbaba ng benta ng COVID-19 products; muling kinumpirma ng kumpanya ang 2026 revenue guidance na $59.5B - $62.5B.
• Inilunsad ang programang "TrumpRx" upang palawakin ang abot-kayang access sa mga gamot sa buong U.S., na sumasalamin sa estratehikong pagbabago ng Pfizer patungo sa mga inisyatiba sa domestic drug pricing at accessibility.
• Nakipag-partner ang Bristol Myers Squibb sa Microsoft upang mag-deploy ng AI-enabled radiology tools para sa mas maagang pagtuklas ng lung cancer sa mga ospital sa U.S., na nagpapakita ng mabilis na pag-adopt ng AI sa sektor.
• Nagbigay ang Merck ng matatag na outlook para sa 2026 na may pagtaas ng Keytruda sales ng 6.8%, ngunit nagbabala ang mga lider ng industriya dahil sa nalalapit na patent cliffs at tumitinding regulasyon sa presyo ng gamot.
See more
about 2D ago

PFE stock price forecast

According to technical indicators for PFE stock, the price is likely to fluctuate within the range of 28.32–35.47 USD over the next week. Market analysts predict that the price of PFE stock will likely fluctuate within the range of 27.45–36.46 USD over the next months.

Based on 1-year price forecasts from 86 analysts, the highest estimate is 65.74 USD, while the lowest estimate is 26.92 USD.

For more information, please see the PFE stock price forecast Stock Price Forecast page.

Latest PFE stock news

Hindi Karaniwang Mga Paggalaw ng Opsyon sa Pfizer: 2 Estratehiyang Yakap ng mga Trader

101 finance2026-01-09 21:38:21

Factbox-Nagmamadaling palakasin ng mga global drugmakers ang presensya sa US habang nagbabantang tumaas ang taripa

101 finance2026-01-13 13:23:24

Bakit Tumataas ang Stocks ng Novavax (NVAX) Ngayon

101 finance2026-01-21 20:53:00

Korte ng Estados Unidos: Ang AstraZeneca, Johnson & Johnson, Pfizer, Roche at iba pang kumpanya ng gamot ay kailangang harapin ang mga paratang ng pagtulong sa mga teroristang grupo sa Iraq

格隆汇2026-01-23 23:15:36

Eli Lilly magtatayo ng $3.5 bilyong planta sa Pennsylvania bilang bahagi ng pagpapalawak ng produksiyon sa US

101 finance2026-01-30 16:14:00

"Ang aming misyon ay talunin ang cancer": Isang pagtingin sa $23 bilyong pamumuhunan ng Pfizer CEO sa oncology matapos ang COVID

101 finance2026-01-30 21:44:57

Pagsusuri—Ang potensyal ng benta sa merkado ng labis na katabaan ay humihigpit habang pumapasok sa bagong panahon sina Novo at Lilly

101 finance2026-02-02 11:17:16

Pfizer: Kita sa ika-apat na quarter ay $17.56 billions, mas mataas kaysa inaasahan

格隆汇2026-02-03 11:55:58

Pangunahing Punto Bago Magbukas ang US Stock Market | Pinagsama ng SpaceX ni Musk at xAI! Lumampas sa inaasahan ang kita ng Palantir, tumaas ng higit sa 11% bago magbukas ang merkado

格隆汇2026-02-03 12:39:18

Bumaba ang kita ng Pfizer dahil sa patuloy na pagbaba ng demand para sa mga gamot laban sa Covid-19

101 finance2026-02-03 13:42:02

S&P 500, Nasdaq nakatakdang tumaas sa pagbubukas habang ang dagsa ng kita ang nasa sentro ng atensyon

101 finance2026-02-03 14:11:46

Ang tatlong pangunahing indeks ng US stock market ay sabay-sabay bumagsak; karamihan sa mga sikat na tech stocks ay bumaba; ang precious metals sector ay tumaas nang salungat sa trend.

格隆汇2026-02-03 22:10:23

Bitget UEX Pang-araw-araw na Ulat|Trump nagtapos ng shutdown ng gobyerno; Ang mga software stocks ay apektado ng AI tools; Plano ng Nvidia na mag-invest ng malaking halaga sa OpenAI (Pebrero 4, 2026)

Bitget2026-02-04 01:15:16

Ang tatlong pangunahing indeks ng US stock market ay nagtapos ng magkahalong resulta; bumagsak ng higit sa 17% ang AMD

格隆汇2026-02-04 22:10:00

Nagbibigay ng positibong pananaw ang Bristol Myers para sa 2026, inaasahang magbebenepisyo mula sa pagbaba ng presyo ng Eliquis

101 finance2026-02-05 12:39:34

Sa isang Bitget account lang, maaari kang mag-trade ng mga stock at cryptocurrencies nang sabay.

Join now!

FAQ

What is the stock price of Pfizer, Inc.?

PFE ay kasalukuyang nakapresyo sa 27.48 USD — ang presyo nito ay nagbago ng 1.59% sa nakalipas na 24 na oras. Maaari mong subaybayan ang pagganap ng presyo ng stock ng Pfizer, Inc. mas malapit sa chart ng presyo sa tuktok ng pahinang ito.

What is the stock ticker of Pfizer, Inc.?

Depende sa exchange, maaaring mag-iba ang stock ticker. Halimbawa, sa NYSE, Pfizer, Inc. ay tini-trade sa ilalim ng ticker PFE.

What is the stock forecast of PFE?

Nagtipon kami ng mga opinyon ng mga analyst tungkol sa Pfizer, Inc.future price. Ayon sa kanilang mga pagtataya, PFE ay may pinakamataas na pagtatantya ng 274.80 USD at isang minimum na pagtatantya ng 54.96 USD.

What is the market cap of Pfizer, Inc.?

Pfizer, Inc. ay may market capitalization ng 156.24B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Risk warning:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official " Fee overview " or " Announcement Center " page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
PFE